Atlas Trials

Targeting Agonists of Glucagon-like Peptide-1 Receptor for Multiple Sclerosis

Clinical trial NCT07497399 · RECRUITING

Trial details

NCT number
NCT07497399
Sponsor
Johns Hopkins University
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Multiple Sclerosis
Start date
2026-04-28
Primary completion
2030-01-01
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.